Katy Beckermann

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Katy Beckermann

Sep 18, 2024, 11:25 | Insight

Toni Choueiri: PEACE-3 phase 3 trials first results at ESMO24

Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X by…

Aug 30, 2024, 16:32 | Blog

Katy Beckermann: Feasibility of an intermittent ipi/nivo approach in their Phase II trial

Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X:…

Aug 15, 2024, 18:25 | Blog

Katy Beckermann: Kidney Cancer Association's Virtual Patient Symposium

Kidney Cancer Association's Virtual Patient Symposium aims to educate patients, caregivers, and the public about…

Jun 27, 2024, 05:29 | Blog

Chandler Park: An honor to co-host with Cathy Eng for the ASCO24 Nashville review

Chandler Park shared on LinkedIn: . “That was FUN! It was an honor to…

Apr 17, 2024, 19:02 | Blog

Katy Beckermann: Exciting update from Dr. Mike Atkins on the novel checkpoint inhibitor LAG3 and its potential role in kidney cancer treatment

Katy Beckermann, Assistant Professor at Vanderbilt University Medical Center, shared a post by GU Oncology…

All: 5 Posts: 1 - 100